Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News GeneDx Holdings Corp WGS

Financial Services Healthcare
GeneDx Holdings Corp. is a genomics company. The Company is focused on delivering personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The Company's segments are GeneDx inclusive of Legacy GeneDx and Legacy Sema4. The GeneDx segment primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing... see more

Recent & Breaking News (NDAQ:WGS)

Sema4 Appoints Computational Biology Expert Gustavo Stolovitzky as Chief Science Officer

GlobeNewswire September 13, 2021

Sema4 Launches Sema4 Elements(TM), a Portfolio of Data Science-Driven Products and Services to Support Reproductive and Generational Health

GlobeNewswire September 9, 2021

Sema4 to Participate at Two Upcoming Investor Conferences in September

GlobeNewswire August 30, 2021

Sema4 Reports Second Quarter 2021 Financial Results and Business Highlights

GlobeNewswire August 16, 2021

Sema4 Closes Transaction with CM Life Sciences, Debuts as Publicly Traded AI-driven Genomic & Clinical Data Platform Company

GlobeNewswire July 22, 2021

Former Magenta Therapeutics and Foundation Medicine CFO Jason Ryan to Join Sema4 Board of Directors

Business Wire July 7, 2021

CM Life Sciences and Sema4 Announce Release of Definitive Proxy Statement for July 21 Shareholder Meeting to Vote on Business Combination

Business Wire July 2, 2021

Sema4 Appoints Andrew Kasarskis, Health Data Expert and Precision Medicine Scientist, as Chief Data Officer

Business Wire June 17, 2021

Sema4 and CM Life Sciences Announce the Filing of Amended Preliminary Proxy Statement

Business Wire June 10, 2021

AdventHealth and Sema4 Launch a Data-driven Precision Medicine Program to Optimize Patient Care and Outcomes

Business Wire May 25, 2021

Sema4 and CM Life Sciences Announce the Filing of the Schedule-14A Proxy Statement in Connection with the Proposed Merger

Business Wire May 6, 2021

CM Life Sciences Announces Filing of Amended Annual Report on Form 10-K Relating to Restatement of Financial Statements in Accordance with Recent SEC Guidance

Business Wire May 5, 2021

NorthShore and Sema4 Launch System-Wide Genomics Program to Improve Primary and Specialty Care with Data-Driven Insights

Business Wire April 19, 2021

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of Investigations of JCS, PACE, CAP, and CMLF Mergers

GlobeNewswire March 19, 2021

CM LIFE SCIENCES INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of CM Life Sciences - CMLF

Business Wire February 24, 2021

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of CM Life Sciences, Inc. - CMLF

PR Newswire February 12, 2021

Moore Kuehn Encourages SYNC, NEBC, FRX, and CMLF Investors to Contact Law Firm

PR Newswire February 12, 2021

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of CM Life Sciences, Inc. Merger

GlobeNewswire February 11, 2021

SHAREHOLDER ALERT: WeissLaw LLP Investigates CM Life Sciences, Inc.

PR Newswire February 11, 2021

SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of CM Life Sciences (NASDAQ:CMLF)

ACCESSWIRE IA February 10, 2021